Maker GlaxoSmithKline Knew of Controversial Diabetes Medication's Risks Years Before They Were Public,...
|
TORONTO - Medical authors with ties to diabetes drug makers were more likely to publish favourable articles...
|
Medical authors with ties to diabetes drug makers were more likely to publish favourable articles on...
|
MONDAY, Feb. 15 (HealthDay News) -- Women who take diabetes drugs known as thiazolidinediones, which...
|
America's Biopharmaceutical Companies Studying 183 New Medicines To Counter Diabetes GrowthA Stratton...
|
American Senate committee has said that GlaxoSmithKline's diabetes drug Avandia poses increased risk...
Source : DNA
| 28 Day(s) Ago
|
a new study, an experimental oral drug successfully lowered blood sugar levels and inflammation in mice...
|
GlaxoSmithKline knew of possible heart attack risks tied to Avandia, its diabetes drug, years before...
Source : Sify
| 28 Day(s) Ago
|
American Heart Association/American College of Cardiology Joint Science Advisory: AHA/ACC Issue Advisory...
|
Lowering blood pressure to normal levels does not reduce the combined risk of fatal or nonfatal cardiovascular...
|
